NYSE:GMED - New York Stock Exchange, Inc. - US3795772082 - Common Stock - Currency: USD
TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 2.48B | 1.57B | 1.02B | 958.10M | 789.00M | |||
Cost Of Goods | 1.04B | 548.17M | 263.70M | 239.20M | 217.50M | |||
Gross Profit | 1.44B | 1.02B | 759.10M | 718.90M | 571.60M | |||
Operating Expenses | 1.27B | 818.45M | 522.90M | 524.00M | 456.10M | |||
Research and Development | 182.60M | 124.01M | 73.00M | 97.30M | 84.50M | |||
Selling, General, and Administrative Expenses | 972.29M | 643.41M | 432.10M | 408.10M | 354.80M | |||
Operating Income | 168.60M | 201.85M | 236.30M | 194.90M | 115.40M | |||
Interest Income/Expense | 6.53M | 34.39M | 13.20M | 7.90M | 13.70M | |||
Other Income/Expense | -1.32M | -2.14M | 1.90M | 600.00K | 800.00K | |||
Non Recurring Items | -52.76M | -68.71M | -8.30M | -22.90M | -4.00M | |||
Income Before Taxes | 121.05M | 165.39M | 243.00M | 180.40M | 125.90M | |||
Income Tax | 29.54M | 42.52M | 52.90M | 31.20M | 23.60M | |||
Net Income | 91.51M | 122.87M | 190.20M | 149.20M | 102.30M | |||
EBITDA | 425.53M | 346.58M | 304.60M | 264.80M | 178.30M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | 0.66 | 1.07 | 1.85 | 1.44 | 1.01 | |||
Non GAAP EPS | 2.90 | 2.33 | 2.07 | 2.04 | 1.43 | |||
Statistics | ||||||||
Gross Profit Margin | 58.14% | 65.05% | 74.22% | 75.03% | 72.45% | |||
Profit Margin | 3.69% | 7.83% | 18.60% | 15.57% | 12.97% | |||
Operating Profit Margin | 6.80% | 12.87% | 23.10% | 20.34% | 14.63% |
All data in USD